NanoViricides

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NanoViricides, Inc. is a clinical stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Enzo Biochem

OPKO Health

Spherix

The COVID-19 outbreak has proved to be a catalyst for biotechs. Some issues that were wallowing in penny stock territory have posted stratospheric gains in the wake of efforts to develop diagnostic tests, treatments and vaccines to combat the new coronavirus.

4 Biotech Stocks Moving On COVID-19 Updates

Altimmune

Clorox

Gilead Sciences

Inovio Pharmaceuticals

Lakeland Industries

Novavax

Zoom Video

The coronavirus fear is now a pandemic, at least in the markets. All major American averages were down over 3% on Friday, after what has been the worst week since the financial crisis more than a decade ago.

The Top Stocks to Beat the Coronavirus Market Scare

Shares of NanoViricides Inc. NNVC, +10.52% soared 33% in premarket trading Monday, after the antiviral therapies company, which previously announced it was working on a COVID-19 treatment, said it had sufficient funding for planned expenditures for this year.

NanoViricides stock soars amid fears of global spread of COVID-19

NanoViricides Will Return To $3-$5 As Soon As The Coronavirus Newsflow Fades

Aethlon Medical

The story that has dominated this past week is that China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up.

Biotech Stocks Seeing the Biggest Boost From Coronavirus Outbreak

Sarepta Therapeutics

China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up.

Coronavirus Infections Climb Hand in Hand With These Biotech Stocks

Allied Healthcare Products

Alpha Pro Tech

BioCryst Pharmaceuticals

Cerus

Co-Diagnostics

Dyadic International Inc., DE

Moderna

Vir Biotechnology

Monday morning brought a huge sell-off in the market as more and more people are concerned about the growing impact of this new coronavirus.

12 Stocks Surging That Could Help Treat or Fight Coronavirus

Shares of a handful of vaccine makers, diagnostics companies and manufacturers of medical supplies, like masks, rallied again in premarket trading on Monday over growing public concern about the new coronavirus. This includes Co-Diagnostics Inc.

Vaccine, diagnostics stocks rise again on spreading coronavirus

AstraZeneca

Cleveland BioLabs

Airlines, hotels, casinos and stocks linked to Wuhan, China, continue to fall as fear of the coronavirus deters international travel and all but halts activity in the virus epicenter.

13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak

SPDR S&P Biotech ETF

Shares of vaccine makers rose sharply again on Thursday, amid rising concerns about the outbreak of a new coronavirus in Wuhan, China that has led the authorities to quarantine the city of 11 million.

Vaccine stocks rise sharply as coronavirus fears mounts

News for NanoViricides Stock (NNVC)